EFPIA warns Europe falling further behind other regions on access to innovative drugs

APM MARKET ACCESS - Europe is falling further behind the U.S. and risks losing ground to China in access to innovative drugs, while patients across the continent continue to face widening inequalities and longer delays to treatment, according to the latest "Patients Waiting to Access Innovative Therapies" (W.A.I.T.) Indicator published on Tuesday by the European pharmaceutical trade body EFPIA. Read more

Picture: Unsplash